NEKTAR THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 USD | +1.59% |
|
-21.95% | +126.55% |
| 09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
| 09/05 | Nektar Therapeutics Reiterates Earnings Guidance for the Year 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS | Other Pharmaceuticals | +1.59% | -21.95% | +126.55% | +106.68% | -95.91% | 23Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NKTR Stock
- Charts Nektar Therapeutics
- Comparison Chart
